|
EPB41L5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.62447832963153E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
3.883000E-01 |
| Stage1-vs-Stage3 |
8.66199999505213E-08 |
| Stage1-vs-Stage4 |
3.08469999987793E-07 |
| Stage2-vs-Stage3 |
2.299800E-02 |
| Stage2-vs-Stage4 |
5.016500E-03 |
| Stage3-vs-Stage4 |
3.036800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.62447832963153E-12 |
| Normal-vs-Asian |
1.00599995001005E-09 |
| Caucasian-vs-AfricanAmerican |
3.503600E-01 |
| Caucasian-vs-Asian |
1.042970E-01 |
| AfricanAmerican-vs-Asian |
2.293000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.039900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
<1E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.205400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.154600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.054600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.527600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.461000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.438600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.44249065417534E-15 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
<1E-12 |
| Grade 1-vs-Grade 2 |
1.719640E-01 |
| Grade 1-vs-Grade 3 |
3.515800E-03 |
| Grade 1-vs-Grade 4 |
2.195900E-04 |
| Grade 2-vs-Grade 3 |
4.554000E-04 |
| Grade 2-vs-Grade 4 |
2.55351295663786E-15 |
| Grade 3-vs-Grade 4 |
1.09579999962861E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
3.14820000002491E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
2.800100E-04 |
|
|
